Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 4/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.30 |
| ▸ | PDE6D | O43924 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22944969 | 0.92 | POLB (0.32) | PIM1PIM2HRH4PDE6DMAPT | |
| SCHEMBL22945534 | 0.92 | ALOX5 (0.34) | ALOX5PRKDCPIK3CDPIK3CBPARP14 | |
| SCHEMBL22945914 | 0.90 | BRDT (0.31) | PIM1PIM2HRH4 | |
| SCHEMBL22946020 | 0.90 | ALOX5 (0.32) | ALOX5PRKDCPIK3CDPIK3CBPARP14 | |
| SCHEMBL22945492 | 0.89 | PDE6D (0.37) | ALOX5PIM1PIM2HRH4PDE6D | |
| SCHEMBL22945441 | 0.89 | ALOX5 (0.32) | ALOX5PRKDCPIK3CDPIK3CBPARP14 | |
| SCHEMBL22944980 | 0.89 | PDE6D (0.35) | PDE6DMAPT | |
| SCHEMBL22945115 | 0.88 | ALOX5 (0.34) | ALOX5PRKDCPIK3CDPIK3CBPARP14 | |
| SCHEMBL22944962 | 0.88 | ALDH1A1 (0.36) | MAPT | |
| SCHEMBL21515448 | 0.87 | ALOX5 (0.34) | ALOX5PRKDCPIK3CDPIK3CBPARP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, DRD3, DRD2 | ALOX5 386/4885PRKDC 4810/4885PIK3CD 4301/4885 |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | DRD1, DRD3, DRD2 | ALOX5 386/4885PRKDC 4810/4885PIK3CD 4301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.